xeplion 150 mg retardsuspension per iniezione intramuscolare
janssen-cilag ag - paliperidonum - retardsuspension per iniezione intramuscolare - paliperidonum 150 mg ut paliperidoni palmitas 234 mg, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, dinatrii phosphas, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabilia ad suspensionem pro 1.5 ml corresp. natrium 5.503 mg. - antipsicotico - synthetika
wakix
bioprojet pharma - pitolisant - narcolessia - altri farmaci sul sistema nervoso - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
relestat collirio
abbvie ag - epinastini hydrochloridum - collirio - epinastinum hydrochloridum 0.5 mg, natrii dihydrogenophosphas dihydricus 7.8 mg, natrii chloridum, dinatrii edetas, benzalkonii chloridum 0,1 mg, acido hydrochloridum o natrii hydroxidum, acqua purificata, per la soluzione 1 ml. - congiuntivite allergica stagionale - synthetika
agomelatin-mepha 25 mg compresse rivestite con film
mepha pharma ag - agomelatinum - compresse rivestite con film - agomelatinum 25 mg ut agomelatinum-ureum, lactosum monohydricum 55.759 mg, calcii hydrogenophosphas dihydricus, carboxymethylamylum natricum a corresp. natrium max. 0.437 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 1.800 mg, hypromellosum, e 172 (flavum), macrogolum 4000, e 171, pro compresso obducto. - antidepressivo - synthetika
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - altri farmaci sul sistema nervoso - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
entacapone hec
hec pharm gmbh - entacapone - entacapone
ontilyv
bial portela & companhia s.a. - opicapone - morbo di parkinson - farmaci anti-parkinson - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
amisulpride op pharma
o.p. pharma s.r.l. - amisulpride - amisulpride
linezolid kabi
fresenius kabi italia s.r.l. - linezolid - linezolid